Researchers suggest drugs that prevent cholesterol from being converted to 24-OHC might therefore be an effective treatment for Parkinson's disease.

Parkinson’s disease may be linked to a cholesterol by-product that helps harmful protein clumps spread in the brain, a ...

| Nearly one million people in the U.S. and more than six million people worldwide have Parkinson's disease (PD), a ...

Parkinson’s disease is a neurodegenerative disease that causes nerve cells in the brain to die leading to impaired movement, ...

Cambridge researchers are developing implants to help repair brain pathways damaged by Parkinson’s disease. As part of a £69 ...

Approval of Onapgo (apomorphine hydrochloride) marks the first and only subcutaneous apomorphine infusion device for managing motor fluctuations in adults with advanced Parkinson disease.

Dr. Raheja highlighted, 'Environmental cues trigger surges in dopamine and glutamate, driving cravings,' reinforcing the need for interventions targeting these pathways. Advances in precision ...

The University of Tasmania will today launch a free Massive Open Online Course (MOOC) on Parkinson's Disease. The course — developed by the University's Wicking Dementia Research and Education ...

"As Parkinson's disease progresses, levodopa treatment often becomes less effective at delivering consistent motor control in part due to GI dysmotility, variable absorption of oral medication, and ...

npg.wustl.edu Objectives: Degeneration of nigrostriatal neurons and subsequent striatal dopamine ... of dopaminergic pathways, producing altered responses to levodopa in brain regions associated with ...

While there is no cure for Parkinson’s disease, an upcoming experiment offers hope to the more than 10 million people living with the disorder that a breakthrough may be on the horizon.

the test is able to identify early signs of Parkinson’s disease in individuals who have not yet shown clinical symptoms, potentially offering a new pathway for earlier intervention and improved ...